Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It d...
Tianfeng Securities: Initiates "Buy" rating for KHPG with a target price of 51.84 yuan
KHPG: Ipasitide tablets have obtained a drug registration certificate
KHPG: Criminals are using the company's name to carry out fraud and other activities
The concept of innovative drugs has strengthened again, with Hotgen rising over 10% to reach a new historical high
KHPG: Currently, production and business activities are normal, and there are no significant matters that should be disclosed but have not been disclosed
KHPG: "KH813 Injection" drug clinical trial approved